Helicobacter pylori infection and stem cells at the origin of gastric cancer

Oncogene

Volumn 34, Issue 20, 2015, Pages 2547-2555

  Bessede E ^a,b   Dubus, P ^a   Megraud F ^a,b   Varon, C ^a,b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSERM U853 ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ANIMAL; CANCER STEM CELL; CELL TRANSFORMATION; CHRONIC DISEASE; EPITHELIAL MESENCHYMAL TRANSITION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFLAMMATION; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; STOMACH NEOPLASMS;

ADENOCARCINOMA; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CHRONIC DISEASE; EPITHELIAL-MESENCHYMAL TRANSITION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFLAMMATION; MESENCHYMAL STROMAL CELLS; NEOPLASTIC STEM CELLS; STOMACH NEOPLASMS;

EID: 84938073835     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.187     Document Type: Review

References (86)

1. IARC'Working'Group. Schistosomes, Liver Flukes and Helicobacter Pylori: Views and Expert Opinion of IARC Working Group on the Evaluation of Carcinogenic Risks to Humans IARC Monographs. International Agency for research on Cancer: Lyon, France 1994; 61: 177-240.
2. HaCCG. Gastric cancer and Helicobacter pylori: A combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001; 49: 347-353.
3. Ekstrom AM, Held M, Hansson LE, Engstrand L, Nyren O. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 2001; 121: 784-791.
4. Gonzalez CA, Megraud F, Buissonniere A, Lujan Barroso L, Agudo A, Duell EJ et al. Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: The Eurgast-EPIC project. Ann Oncol. 2012; 23: 1320-1324.
5. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: An open-label, randomised controlled trial. Lancet 2008; 372: 392-397.
6. Lee YC, Chen TH, Chiu HM, Shun CT, Chiang H, Liu TY et al. The benefit of mass eradication of Helicobacter pylori infection: A community-based study of gastric cancer prevention. Gut 2013; 62: 676-682.
7. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: A randomized controlled trial. JAMA 2004; 291: 187-194.
8. Cai X, Carlson J, Stoicov C, Li H, Wang TC, Houghton J. Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL/mice. Gastroenterology 2005; 128: 1937-1952.
9. De Sablet T, Piazuelo MB, Shaffer CL, Schneider BG, Asim M, Chaturvedi R et al. Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk. Gut 2011; 60: 1189-1195.
10. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 1998; 115: 642-648.
11. Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, Dixon MF. A standardized mouse model of Helicobacter pylori infection: Introducing the Sydney strain. Gastroenterology 1997; 112: 1386-1397.
12. Rogers AB, Taylor NS, Whary MT, Stefanich ED, Wang TC, Fox JG. Helicobacter pylori but not high salt induces gastric intraepithelial neoplasia in B6129 mice. Cancer Res 2005; 65: 10709-10715.
13. Thompson LJ, Danon SJ, Wilson JE, O'Rourke JL, Salama NR, Falkow S et al. Chronic Helicobacter pylori infection with Sydney strain 1 and a newly identified mouseadapted strain (Sydney strain 2000) in C57BL/6 and BALB/c mice. Infect Immun 2004; 72: 4668-4679.
14. Hahm KB, Lee KM, Kim YB, Hong WS, Lee WH, Han SU et al. Conditional loss of TGF-beta signalling leads to increased susceptibility to gastrointestinal carcinogenesis in mice. Alimentary pharmacology & therapeutics 2002; 16: 115-127.
15. Fox JG, Wang TC, Rogers AB, Poutahidis T, Ge Z, Taylor N et al. Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia. Gastroenterology 2003; 124: 1879-1890.
16. Ohtani M, Garcia A, Rogers AB, Ge Z, Taylor NS, Xu S et al. Protective role of 17 beta-estradiol against the development of Helicobacter pylori-induced gastric cancer in INS-GAS mice. Carcinogenesis 2007 Dec; 28: 2597-2604.
17. Takaishi S, Cui G, Frederick DM, Carlson JE, Houghton J, Varro A et al. Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacterinduced gastric cancer. Gastroenterology 2005; 128: 1965-1983.
18. Kuzushita N, Rogers AB, Monti NA, Whary MT, Park MJ, Aswad BI et al. p27kip1 deficiency confers susceptibility to gastric carcinogenesis in Helicobacter pylori-infected mice. Gastroenterology 2005; 129: 1544-1556.
19. Fox JG, Rogers AB, Whary MT, Ge Z, Ohtani M, Jones EK et al. Accelerated progression of gastritis to dysplasia in the pyloric antrum of TFF2 ?/? C57BL6 x Sv129 Helicobacter pylori-infected mice. Am J Pathol 2007; 171: 1520-1528.
20. Tu S, Bhagat G, Cui G, Takaishi S, Kurt-Jones EA, Rickman B et al. Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell 2008; 14: 408-419.
21. Judd LM, Bredin K, Kalantzis A, Jenkins BJ, Ernst M, Giraud AS. STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis. Gastroenterology 2006; 131: 1073-1085.
22. Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, De Boni M et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-577.
23. Lauren P. The two histological main types of gastric carcinoma: Diffuse and socalled intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49.
24. Correa P. Human gastric carcinogenesis: A multistep and multifactorial process -First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52: 6735-6740.
25. Cahill RJ, Kilgallen C, Beattie S, Hamilton H, O'Morain C. Gastric epithelial cell kinetics in the progression from normal mucosa to gastric carcinoma. Gut 1996; 38: 177-181.
26. Moss SF, Calam J, Agarwal B, Wang S, Holt PR. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 1996; 38: 498-501.
27. Touati E, Michel V, Thiberge JM, Wuscher N, Huerre M, Labigne A. Chronic Helicobacter pylori infections induce gastric mutations in mice. Gastroenterology 2003; 124: 1408-1419.
28. Kang GH, Lee HJ, Hwang KS, Lee S, Kim JH, Kim JS. Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am J Pathol 2003; 163: 1551-1556.
29. Wu CY, Kuo KN, Wu MS, Chen YJ, Wang CB, Lin JT. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. Gastroenterology 2009; 137: 1641-1648 e1-2.
30. Suzuki R, Shiota S, Yamaoka Y. Molecular epidemiology, population genetics, and pathogenic role of Helicobacter pylori. Infect Genet Evol 2012; 12: 203-213.
31. Atherton JC, Peek Jr RM, Tham KT, Cover TL, Blaser MJ. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology 1997; 112: 92-99.
32. Ferreira RM, Machado JC, Letley D, Atherton JC, Pardo ML, Gonzalez CA et al. A novel method for genotyping Helicobacter pylori vacA intermediate region directly in gastric biopsy specimens. J Clin Microbiol. 2012; 50: 3983-3989.
33. Galmiche A, Rassow J, Doye A, Cagnol S, Chambard JC, Contamin S et al. The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release. EMBO J 2000; 19: 6361-6370.
34. Cover TL, Krishna US, Israel DA, Peek RM Jr. Induction of gastric epithelial cell apoptosis by Helicobacter pylori vacuolating cytotoxin. Cancer Res 2003; 63: 951-957.
35. Gebert B, Fischer W, Weiss E, Hoffmann R, Haas R. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science (New York, NY) 2003; 301: 1099-1102.
36. Ghiara P, Marchetti M, Blaser MJ, Tummuru MK, Cover TL, Segal ED et al. Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease. Infect Immun 1995; 63: 4154-4160.
37. Marchetti M, Arico B, Burroni D, Figura N, Rappuoli R, Ghiara P. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science (New York, NY) 1995; 267: 1655-1658.
38. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 2111-2115.
39. Kuipers EJ, Perez-Perez GI, Meuwissen SG, Blaser MJ. Helicobacter pylori and atrophic gastritis: Importance of the cagA status. J Natl Cancer Inst. 1995; 87: 1777-1780.
40. Occhialini A, Marais A, Urdaci M, Sierra R, Munoz N, Covacci A et al. Composition and gene expression of the cag pathogenicity island in Helicobacter pylori strains isolated from gastric carcinoma and gastritis patients in Costa Rica. Infect Immun 2001; 69: 1902-1908.
41. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997; 40: 297-301.
42. Backert S, Selbach M. Role of type IV secretion in Helicobacter pylori pathogenesis. Cell Microbiol. 2008; 10: 1573-1581.
43. Backert S, Clyne M, Tegtmeyer N. Molecular mechanisms of gastric epithelial cell adhesion and injection of CagA by Helicobacter pylori. Cell Commun Signal 2011; 9: 28.
44. Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol. 2004; 5: 1166-1174.
45. Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science (New York, NY) 2002; 295: 683-686.
46. Lu H, Murata-Kamiya N, Saito Y, Hatakeyama M. Role of partitioning-defective 1/microtubule affinity-regulating kinases in the morphogenetic activity of Helicobacter pylori CagA. J Biol Chem 2009; 284: 23024-23036.
47. Backert S, Tegtmeyer N, Selbach M. The versatility of Helicobacter pylori CagA effector protein functions: The master key hypothesis. Helicobacter 2010; 15: 163-176.
48. Ohnishi N, Yuasa H, Tanaka S, Sawa H, Miura M, Matsui A et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci USA 2008; 105: 1003-1008.
49. Leblond CP, Stevens CE, Bogoroch R. Histological localization of newly-formed desoxyribonucleic acid. Science 1948; 108: 531-533.
50. Okumura T, Ericksen RE, Takaishi S, Wang SS, Dubeykovskiy Z, Shibata W et al. K-ras mutation targeted to gastric tissue progenitor cells results in chronic inflammation, an altered microenvironment, and progression to intraepithelial neoplasia. Cancer Res 2010; 70: 8435-8445.
51. Peterson AJ, Menheniott TR, O'Connor L, Walduck AK, Fox JG, Kawakami K et al. Helicobacter pylori infection promotes methylation and silencing of trefoil factor 2, leading to gastric tumor development in mice and humans. Gastroenterology 2010; 139: 2005-2017.
52. Quante M, Marrache F, Goldenring JR, Wang TC. TFF2 mRNA transcript expression marks a gland progenitor cell of the gastric oxyntic mucosa. Gastroenterology 2010; 139: 2018-2027 e2.
53. Barker N, Huch M, Kujala P, van De Wetering M, Snippert HJ, van Es JH et al. Lgr5 (+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. Cell Stem Cell 2010; 6: 25-36.
54. Wu C, Xie Y, Gao F, Wang Y, Guo Y, Tian H et al. Lgr5 expression as stem cell marker in human gastric gland and its relatedness with other putative cancer stem cell markers. Gene 2013; 525: 18-25.
55. Nam KT, Lee HJ, Sousa JF, Weis VG, O'Neal RL, Finke PE et al. Mature chief cells are cryptic progenitors for metaplasia in the stomach. Gastroenterology 2010; 139: 2028-2037 e9.
56. Qiao XT, Ziel JW, McKimpson W, Madison BB, Todisco A, Merchant JL et al. Prospective identification of a multilineage progenitor in murine stomach epithelium. Gastroenterology 2007; 133: 1989-1998.
57. Stange DE, Koo BK, Huch M, Sibbel G, Basak O, Lyubimova A et al. Differentiated Troy+ chief cells act as reserve stem cells to generate all lineages of the stomach epithelium. Cell 2013; 155: 357-368.
58. Takaishi S, Okumura T, Tu S, Wang SS, Shibata W, Vigneshwaran R et al. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells (Dayton, OH) 2009; 27: 1006-1020.
59. Ponta H, Sherman L, Herrlich PA. CD44: From adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol. 2003; 4: 33-45.
60. Solis MA, Chen YH, Wong TY, Bittencourt VZ, Lin YC, Huang LL. Hyaluronan regulates cell behavior: A potential niche matrix for stem cells. Biochem Res Int 2012; 2012: 346972.
61. Su YJ, Lai HM, Chang YW, Chen GY, Lee JL. Direct reprogramming of stem cell properties in colon cancer cells by CD44. EMBO J 2011; 30: 3186-3199.
62. Khurana SS, Riehl TE, Moore BD, Fassan M, Rugge M, Romero-Gallo J et al. The hyaluronic acid receptor CD44 coordinates normal and metaplastic gastric epithelial progenitor cell proliferation. J Biol Chem 2013; 288: 16085-16097.
63. Houghton J, Stoicov C, Nomura S, Rogers AB, Carlson J, Li H et al. Gastric cancer originating from bone marrow-derived cells. Science (New York, NY) 2004; 306: 1568-1571.
64. Varon C, Dubus P, Mazurier F, Asencio C, Chambonnier L, Ferrand J et al. Helicobacter pylori infection recruits bone marrow-derived cells that participate in gastric preneoplasia in mice. Gastroenterology 2012; 142: 281-291.
65. Nam KT, Lee HJ, Mok H, Romero-Gallo J, Crowe Jr JE, Peek Jr, RM et al. Amphiregulin-deficient mice develop spasmolytic polypeptide expressing metaplasia and intestinal metaplasia. Gastroenterology 2009; 136: 1288-1296.
66. Weis VG, Goldenring JR. Current understanding of SPEM and its standing in the preneoplastic process. Gastric Cancer. 2009; 12: 189-197.
67. Ferrand J, Lehours P, Schmid-Alliana A, Megraud F, Varon C. Helicobacter pylori infection of gastrointestinal epithelial cells in vitro induces mesenchymal stem cell migration through an NF-kappaB-dependent pathway. PLoS ONE 2011; 6: E29007.
68. Ferrand J, Noel D, Lehours P, Prochazkova-Carlotti M, Chambonnier L, Menard A et al. Human bone marrow-derived stem cells acquire epithelial characteristics through fusion with gastrointestinal epithelial cells. PLoS ONE 2011; 6: E19569.
69. Hutchinson L, Stenstrom B, Chen D, Piperdi B, Levey S, Lyle S et al. Human Barrett's adenocarcinoma of the esophagus, associated myofibroblasts, and endothelium can arise from bone marrow-derived cells after allogeneic stem cell transplant. Stem Cells Dev 2011; 20: 11-17.
70. Sarosi G, Brown G, Jaiswal K, Feagins LA, Lee E, Crook TW et al. Bone marrow progenitor cells contribute to esophageal regeneration and metaplasia in a rat model of Barrett's esophagus. Dis Esophagus 2008; 21: 43-50.
71. Janin A, Murata H, Leboeuf C, Cayuela JM, Gluckman E, Legres L et al. Donor-derived oral squamous cell carcinoma after allogeneic bone marrow transplantation. Blood 2009; 113: 1834-1840.
72. Worthley DL, Ruszkiewicz A, Davies R, Moore S, Nivison-Smith I, Bik To L et al. Human gastrointestinal neoplasia-associated myofibroblasts can develop from bone marrow-derived cells following allogeneic stem cell transplantation. Stem cells (Dayton, OH) 2009; 27: 1463-1468.
73. Almeida R, Almeida J, Shoshkes M, Mendes N, Mesquita P, Silva E et al. OCT-1 is over-expressed in intestinal metaplasia and intestinal gastric carcinomas and binds to, but does not transactivate, CDX2 in gastric cells. J Pathol 2005; 207: 396-401.
74. Barros R, da Costa LT, Pinto-de-Sousa J, Duluc I, Freund JN, David L et al. CDX2 autoregulation in human intestinal metaplasia of the stomach: Impact on the stability of the phenotype. Gut 2011; 60: 290-298.
75. Zhu Y, Jiang Q, Lou X, Ji X, Wen Z, Wu J et al. MicroRNAs up-regulated by CagA of Helicobacter pylori induce intestinal metaplasia of gastric epithelial cells. PLoS ONE 2012; 7: E35147.
76. Amieva MR, Vogelmann R, Covacci A, Tompkins LS, Nelson WJ, Falkow S. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science (New York, NY) 2003; 300: 1430-1434.
77. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119: 1420-1428.
78. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002; 2: 442-454.
79. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-715.
80. Segal ED, Cha J, Lo J, Falkow S, Tompkins LS. Altered states: Involvement of phosphorylated CagA in the induction of host cellular growth changes in Helicobacter pylori. Proc Natl Acad Sci USA 1999; 96: 14559-14564.
81. Bagnoli F, Buti L, Tompkins L, Covacci A, Amieva MR. Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. Proc Natl Acad Sci USA 2005; 102: 16339-16344.
82. Yin Y, Grabowska AM, Clarke PA, Whelband E, Robinson K, Argent RH et al. Helicobacter pylori potentiates epithelial:mesenchymal transition in gastric cancer: Links to soluble HB-EGF, gastrin and matrix metalloproteinase-7. Gut 2010; 59: 1037-1045.
83. Baud J, Varon C, Chabas S, Chambonnier L, Darfeuille F, Staedel C. Helicobacter pylori initiates a mesenchymal transition through ZEB1 in gastric epithelial cells. PLoS ONE 2013; 8: E60315.
84. Bessède E, Staedel C, Acuna Amador LA, Nguyen PH, Chambonnier L, Hatakeyama M et al. Helicobacter pylori generates cells with cancer stem cell properties via epithelial-mesenchymal transition-like changes. Oncogene 2013.
85. Palena C, Hamilton DH, Fernando RI. Influence of IL-8 on the epithelial-mesenchymal transition and the tumor microenvironment. Fut Oncol (London, England) 2012; 8: 713-722.
86. Watanabe T, Takahashi A, Suzuki K, Kurusu-Kanno M, Yamaguchi K, Fujiki H et al. Epithelial-mesenchymal transition in human gastric cancer cell lines induced by TNF-alpha-inducing protein of Helicobacter pylori. Int J Cancer 2014; 134: 2373-2382.